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Background
The emergence of artemisinin resistance in South East
Asia threatens the efficacy of artemisinin derivatives (AD).
Since the pharmacodynamic hallmark of AD is rapid para-
site clearance, the clinical phenotype of slow clearance
characterises resistance. This indicator remains critically
important to monitor the extent of the problem in the
absence of molecular marker(s) associated with artemisi-
nin resistance and lack of sensitivity of current in vitro
tests. Frequent parasite counts are needed to define clear-
ance rate but it is uncertain what sampling frequency is
required to ensure reliable estimates.
Materials and methods
WWARN established a study group project to assess
this question. Twelve studies with 4552 patients with
frequent parasite counts, from Cambodia, Thailand,
Laos, Bangladesh, Mali, Tanzania and Kenya were
included in the analysis. Patients were treated with arte-
sunate alone or in combination with a partner drug.
The WWARN Parasite Clearance Estimator [1,2] was
used to produce standardized estimates of parasite half-
life (HL). Parasitaemia-time profiles with 6-hourly para-
site counts available in the first 48 hours (h) were used
to examine the effect of different sampling strategies on
HL estimates - four measurement schedules were inves-
tigated at: (a) 0,6,12,24 or (b) 0,6,18,24 or (c) 0,12,18,24
or (d) 0,12,24 h and then every 12h. Bootstrapping was
used to estimate the sampling distribution of HLs for
subsets of the profiles with different distributions of
HLs. A simulation study was performed to investigate
optimal schemes. Parasite counts were generated from
an overdispersed Poisson distribution based on the
variability observed in the study data and assuming a
first order elimination process.
Results
The median (range) of estimated HLs was 3.1 h (0.6-17.4).
Estimates varied significantly between study location and
year (p<0.001), with median HLs ranging from 1.9-6.3 h
and the coefficient of variation ranging from 26-52%
between studies. Nearly 50% (2251/4552) of the profiles
had 6-hourly counts. In these profiles the median (range)
for the difference between the original HL estimate and
that from the 4 schemes were -0.02 (-3.4 to 3.8), -0.06
(-3.3 to 3.5), -0.09 (-3.6 to 3.4), -0.15 (-5.0 to 3.6) h, respec-
tively. The overestimation of the HL by the restricted
schemes was greater for profiles with short reference HL.
Boostraping showed that the median HL was overesti-
mated by the 4 schemes in the majority of bootstrap sam-
ples. The schemes overestimated the proportion (%) of
profiles with a HL >3h, on average by 6,7,9,12% in boot-
strap samples with slow clearing parasites (50% of HL
longer than 3h) and 39,44, 54, 72% in bootstrap samples
with fast clearing parasites (20% of HL longer than 3h),
relative to the scheme with 6 hourly measurements. A
number of alternative sampling designs derived from the
simulation study will be presented and discussed.
Conclusion
Our data indicate that the estimation of HL is depen-
dent on sampling times for fast clearing parasites.
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12 hourly counting is satisfactory in patients with slow
clearance but the estimation of short HLs requires more
sophisticated sampling schemes. Suggested schemes will
need to be tested in a clinical study.
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